Sensi.AI vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Sensi.AI provides an audio-based AI monitoring platform for home care agencies and senior living facilities; detects health and safety events in real time from ambient sound without cameras; raised $31M Series B;
About
Sensi.AI is a Tel Aviv and Austin-based healthcare AI company founded in 2019 by Rafi Zauer and Doron Telem. The platform uses small, discreet audio devices installed in senior living environments — private homes, assisted living facilities, and memory care units — to continuously monitor ambient sound and detect health and safety events using AI. Unlike camera-based monitoring that raises privacy concerns, Sensi.AI's audio-only approach detects falls, respiratory distress, unusual movement patterns, and behavioral changes while preserving resident and patient dignity.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.